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The last decade has overwhelmed the surgical community with options regarding the
treatment of patients with thoracic aortic pathology involving the aortic arch as to a point
where supply exceeds demand. Consequently, surgeons are confronted with a new chal-
lenge being weighing conventional surgery to several other options where some are good,
some are bad and some are ugly. This manuscript is meant to serve as a pragmatic
companion for the interested physician in accompanying patients with thoracic aortic
disease through the natural history of the disease, to indicate the right time for treatment
with adequate risk stratiﬁcation, to balance options and to do the right things when
advancing to treatment.
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The last decade has overwhelmed the surgical community
with options regarding the treatment of patients with
thoracic aortic pathology involving the aortic arch as to a
point where supply exceeds demand. Consequently, surgeons
are confronted with a new challenge being weighing
conventional surgery to several other options where some
are good, some are bad and some are ugly. This manuscript is
meant to serve as a pragmatic companion for the interested
physician in accompanying patients with thoracic aortic
disease through the natural history of the disease, to indicate
the right time for treatment with adequate risk stratiﬁcation,
to balance options and to do the right things when advancing
to treatment.
Natural history
Interestingly, the scientiﬁc basis for our decision makings
when indicating the time point for intervention is mainly
based on historical morphological studies as we continue to
rely on maximum diameters and few advances have been
made beyond conventional size criteria [1]. Anyhow we know
that aneurysms will rupture sooner or later, dissections will
occur with a dismal natural course without treatment and the
natural history of penetrating atherosclerotic ulcers is an
aggressive one without a clear correlation to diameter. Several
approaches to add functional information are under way but
functional imaging has not yet been fully entering the clinical
arena so that maximum diameter remains our most robust
surrogate of risk and thereby indication for treatment with a
general consent of indicating treatment between 5 and 6 cm
according to segment, accompanying valve disease, family
history, additional risk factors or connective tissue component
[2].
Timing/risk stratiﬁcation
‘‘Intervention is indicated when the probability of experienc-
ing an aortic-related event is higher than the remaining risk of
treatment’’. As easy as this sentence is written, as complex the
decision making process may be. Finally, there is no risk
stratiﬁcation score in predicting the risk of treatment as there
is in adult cardiac surgery [3]. So other approximations have to
be chosen.
A fundamental difference between proximal thoracic aortic
aneurysms, dissections type A/B as well as intramural
hematoma (IMH) on the one hand and penetrating atheroscle-
rotic ulcers (PAU) on the other hand is the fact that the latter
ones have an obliterative basis where the ﬁrst group is on the
basis of dilatative arteriopathy [4,5].
This is important as patients with proximal thoracic aortic
aneurysms, dissections type A/B as well as IMH will almost
never be affected by obliterative components or in other words
coronary artery disease (CAD) as these two are nearly mutually
exclusive whereas patients with PAU will very often have
severe CAD as they do have peripheral arterial occlusivedisease which often challenges delivery of stent-grafts
through the iliac axis.
Furthermore, cuspidity of the aortic valve is an issue as
patients with bicuspid aortic valve disease are less likely to
have CAD as this also seems a kind of protecting issue [6]. After
all these considerations are vital as the let us call it
‘‘obliterative load’’ in patients with PAU is high as is the risk
of collateral injury by stroke and myocardial infarction (MI)
whereas the obliterative load in patients with proximal
thoracic aortic aneurysms, dissections type A/B as well as
IMH is very low and collateral injury with regard to stroke and
MI is very low.
Finally, and this is interesting, ventricular function in the
vast majority in patients with thoracic aortic disease is regular
which should be seen as a prerequisite for successful
treatment as – this is a lesson of the personal experience of
the author – patients with thoracic aortic disease and severely
reduced ventricular function are at risk to die with thoracic
aortic disease but not to die from thoracic aortic disease.
Summarizing, successful treatment of extensive thoracic
aortic pathology will be achieved when disease of the aorta is
the only limiting problem of the presenting individual, any
other limiting disease burden will put success into perspective.
Balancing options and doing the right things
The most misused sentence by non-aortic surgeons is
‘‘Conventional aortic arch surgery is still associated with
signiﬁcant morbidity and mortality.’’ There is overwhelming
evidence that thoracic aortic surgery involving the aortic arch
is a safe and highly efﬁcient procedure with low perioperative
morbidity and mortality in the elective setting as well as in
emergencies – predominantly acute type A aortic dissection –
as long as they are uncomplicated meaning without irrevers-
ible organ malperfusion, cerebral or visceral [7–9]. Without
doubt, we aim at reducing neurological injury – predominantly
cerebral – to a minimum but there is work to do. Modiﬁed
perfusion protocols, the routine implementation of selective
antegrade cerebral perfusion and the move to warmer
hypothermic circulatory arrest temperature have substantial-
ly aided in optimizing outcome [10].
Nevertheless, there are options available and some of them
are important adjuncts to the armamentarium of the aortic
surgeon in the decision algorithm. When discussing treatment
of aortic arch pathologies we have to be very clear upon the
underlying pathology as well as the segmental affection.
Proximal thoracic aortic pathology originating from secondary
heart ﬁelds, from the aortic root or from the ascending aorta up
to the aortic arch and beyond are a very clear domain of
conventional aortic surgery [10–12].
Here a relatively new approach has gained increasing
acceptance being the so-called ‘‘frozen elephant trunk
technique’’. The principle is the combination of a distal
stent-graft with a continuing transition to a conventional
Dacron prosthesis for treating patients with Megaaortas
thereby reducing a potentially two-step approach to a one-
step operation or to treat type A/type B acute aortic dissections
with malperfusion and an entry tear at a level where
conventional surgical repair is ineffective or ﬁnally patients
Fig. 1 – Postoperative CT scan after FET implantation.
Fig. 2 – Intraoperative situs during subclavian-to-carotid
artery transposition.
Reprinted from Czerny et al., Transposition of the supra-
aortic vessels before stent grafting the aortic arch and
descending aorta, J. Thorac. Cardiovasc. Surg. 145 (3 Suppl.)
S91–S97, Copyright (2013), with permission from Elsevier.
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needed, this approach is a valuable alternative to conventional
surgery. The European Association of Cardio-Thoracic Surgery
recently published a position paper on the recommendations
for use of the method [13]. Fig. 1 depicts a completion CT scan
after FET implantation.
Isolated aortic arch pathology is rare and may be
approached by open surgical approach, a combined vascular
and endovascular approach or by total endovascular aortic
arch repair according to the individual situation [14–16]. We
will go into detail later in this chapter.
The vast majority of patients suitable for combined
vascular and endovascular approaches are the ones with
multisegmental thoracic aortic pathology originating at the
level of the aortic arch. The aim of transposition always is to
create a sufﬁcient landing zone length for safe deployment of
the stent-graft. General consent through all scientiﬁc societies
recommends at least 2 cm of proximal (or distal) landing zone
for a durable result [17]. However, evidence increases that 2 cm
might not be sufﬁcient to guarantee a stable long-term result,
in other words, the longer the landing-zone, the more durable
the result. Finally, other aspects as respecting geometry and
angulations are important details distinguishing success from
failure [18].
Regarding transposition, in-general three options are
available being subclavian-to-carotid transposition, double
transposition or total arch rerouting, we will shortly go
through all three methods.
Subclavian-to-carotid transposition. This operation has
gained recurring interest as it has been primarily developed forocclusive disease where intervention is the primary strategy.
Our preferred approach is the medial one where surgical
access is gained between the insertions of the sternocleido-
mastoid muscle. This approach minimizes need for dissection,
reduces collateral nerve injury and simpliﬁes exposure. If
needed, an alloplastic graft may be used but autologous
transposition is feasible in the majority of cases. Results are
very good [15,19]. Fig. 2 shows the intraoperative situs during
subclavian-to-carotid artery transposition using the medial
approach – surgical exposure between the two insertions of
the sternocleidomastoid muscle.
Double transposition. This approach extends the concept of
subclavian-to-carotid transposition to the level of the bra-
chiocephalic trunk. Surgical access is gained via an upper
median hemi-sternotomy, the left common carotid artery is
transsected at its origin and inserted into the brachiocephalic
trunk in an end-to-side fashion. Afterwards an intrathoracic
subclavian-to-carotid transposition is performed. Results are
very good [15]. Fig. 3 shows the intraoperative situs during
double transposition.
Total arch rerouting. This operation extends transposition
to the level of the ascending aorta by using either a reversed
bifurcated graft or a tube graft with side-branches. We have
stopped this approach due to the high incidence of retrograde
type A aortic dissection. There are several reasons for
observing retrogade type A aortic dissection with the probably
most important ones being the underlying pathology of an
acute type B aortic syndrome as well as an ectatic ascending
aorta where – due to the lessons learned – prophylactic
ascending aortic replacement in diameters above 37 mm is
recommended [15,20,21]. Fig. 4 shows the intraoperative situs
during total arch rerouting.
Total endovascular approaches. Recently, trade-offs have
entered the clinical arena using so-called chimney/periscopes
and snorkels for preserving side-branch perfusion in the aortic
arch as well as in the thoracoabdominal aorta. These strategies
Fig. 3 – Intraoperative situs during double transposition.
Reprinted from Czerny et al., Transposition of the supra-
aortic vessels before stent grafting the aortic arch and
descending aorta, J. Thorac. Cardiovasc. Surg. 145 (3 Suppl.)
S91–S97, Copyright (2013), with permission from Elsevier.
Fig. 4 – Intraoperative situs during total arch rerouting.
Reprinted from Czerny et al., Transposition of the supra-
aortic vessels before stent grafting the aortic arch and
descending aorta, J. Thorac. Cardiovasc. Surg. 145 (3 Suppl.)
S91–S97, Copyright (2013), with permission from Elsevier.
Fig. 5 – Completion CT scan after total endovascular arch
repair using a branched prosthesis.
Courtesy of Dr. Timothy Resch, University Hospital Malmö,
Sweden.
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dangerous as the method relies on counteracting radial forces
of the main graft and the supplying side-branch graft with the
potential of material fatigue of one or the other [22].
Furthermore, type I endoleakage is very high and has to be
regarded as a treatment failure despite attempts to downgrade
the importance of type I endoleaks.
Branched prostheses for the aortic arch. This approach is
here to stay, does already and will continue to complete the
armamentarium of the aortic surgeon in treating thoracic
aortic pathology involving the aortic arch. Recent literature
conﬁrms safety and reproducibility of this approach [16]. The
concept basically is a modular prosthesis with a cabrio portion
for the arch vessels with inner branches where the extensions
to exclude the pathology from bloodstream are inserted via a
cutdown at the level of both common carotid arteries. As these
devices have two branches, revascularization of the left
subclavian artery has to be done in advance when needed
[23]. Fig. 5 shows a completion CT scan after total endovascular
arch repair using a branched prosthesis.
After having gone through all available options and after
having gained an overview, we would aim at suggesting an
algorithm how to balance available options and aiming to do
the right things.
Conventional proximal thoracic aortic surgery remains the
proven best option when aortic pathology is the limiting
disease. It remains to the discretion of the individually treating
physician which surgical technique is chosen, branched grafts,
island reimplantation, in case of anticipated secondary distal
extension either conventional elephant trunk technique or the
frozen elephant trunk technique. Regarding concomitant
treatment of the aortic root, we follow a liberal approach in
root replacement in patients where the Sinus of Valsalva has a
diameter above 4 cm, in particular in bicuspid aortic valve
disease but the intraoperative clinical hinge point is the wall
quality of the non-coronary sinus as this is in the author'sexperience the weakest segment. Trade-offs during primary
surgery have also been identiﬁed as the main reason for the
need of aortic root redo surgery [24].
Recent literature conﬁrms a trend in Europe toward warmer
circulatory arrest temperatures and an increased application
of selective antegrade cerebral perfusion [2,10]. The author's
strategy is to aim for a core temperature between 26 8C and
30 8C dependent onto the expected hypothermic circulatory
arrest time with bilateral antegrade cerebral perfusion not
c o r e t v a s a 5 7 ( 2 0 1 5 ) e 1 4 3 – e 1 4 8 e147exceeding a ﬂow of 6 ml/kg bodyweight in order to avoid
potential hyperperfusion. In any case, perfusion is adjusted to
bilateral near infrared spectroscopy (NIRS) measurements.
In case of aneurysmal dilation after previous repair, the
decision making process has two components – clinical
condition including concomitant cardiovascular disease as
well as the underlying aortic pathology. Unless we will have a
risk score aiding in predicting, experience and personal
opinion will lead the direction and it is difﬁcult to provide
an algorithm. Finally, clinical assessment will set the path.
Regarding the underlying disease it is of fundamental
difference if there is classical aneurysmal disease or post-
dissection aneurysmal disease as the latter one needs
thorough assessment as to the efﬁcacy of any endovascular
approach due to the fact that there is usually no distal landing
zone and exclusion of the false lumen may be challenging but
forms the basis of long-term success. Regarding the applica-
tion of rerouting procedures, we always aim at creating a
landing-zone of at least 2–3 cm, the longer the better as there is
multiple evidence that the length of the landing zone is an
independent predictor of success or failure [15,17,18]. Depen-
dent onto the needed length subclavian-to-carotid transposi-
tion or double transposition is applied. Total arch rerouting is
not routinely used as to the unpredictable issue of retrograde
type A aortic dissection and in case of an ascending aorta of
more than 37 mm, prophylactic ascending aortic replacement
is pursued [20,21].
In case of extensive thoracic aneurysmal disease with the
potential need for distal extension the author uses the frozen
elephant trunk techniques also in cases where a conventional
secondary surgical procedure is planned as the FET technique
provides ideal stability and an anastomosis between the stent-
graft and a conventional Dacron prosthesis is feasible [25].
In case of post-dissection aneurysmal disease several
aspects have to be considered in particular number and size
of the communications between the lumina as the more in
number and the larger in diameter, the less likely remodeling
becomes [26]. Ideally, there is no communication between the
lumina at the thoracic level as this increases the probability of
complete exclusion of the false lumen from the circulation.
Recently, several additional approaches to enhance exclusion
of the false lumen from the circulation have been described
and should be considered if needed [27,28].
In patients with PAU, the author recommends a thorough
cardiovascular workup as the atherosclerotic load of these
patients is very high and might be more limiting that the aortic
component. Usually, after work-up it becomes evident that
other interventions are warranted such as percutaneous
coronary interventions or carotid artery surgery, up to 21%
in the author's experience [5].
Need for centralization of aortic pathology. Aortic centers.
The logical consequence of the evolution of aortic surgery and
to reconcile heterogeneity of treatment modalities is the
creation of aortic centers capable of treating the entire organ
with all diagnostic and therapeutic options. The leaders of
such centers are likely to be cardio-vascular surgeons with
experience in both cardiac and vascular surgical disciplines
including endovascular skills. All treatment options should be
available for the individual patient with consensus of
treatment choice being decided at multidisciplinary teammeetings (MDT). These MDT meetings are expected to be
populated by open and endovascular surgeons, cardiologists,
cardiovascular physicians, interventional, diagnostic radiolo-
gists and neurophysiologists. Additional expertise including
anesthesiology, rheumatology and microbiology will be
essential when evaluating treatment options. The referral
pattern of an aortic center must be similar to the referral
pattern for percutaneous cardiological interventions with a 24/
7 365 availability. Regarding referral patterns, cardio-vascular
surgeons can have their own recruitment of aortic lesions if
they screen more systematically the cardio-vascular popula-
tion they already have [29].
Summarizing, aortic pathology is a rapidly evolving ﬁeld
fascinating several specialities with the unique chance to work
and grow together. It is our task to take appropriate advantage
of this situation as the question today is not any more if open
surgery or endovascular therapy of thoracic aortic pathology
involving the aortic arch is chosen but the task is to do the right
things by having the entire treatment armamentarium in one
specialized environment.
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